Introduction
Platelet activating factor (PAF) is a choline glycerophospholipid in the alkyl ether subclass containing acetate at the sn-2 position. The predominant PAF molecular species have either a hexadecyl (16:0), octadecyl (18:0) or octadec-cis-9-enyl (18:1) aliphatic alkyl ether at the sn-1 position. PAF is an important biological mediator in physiological and pathophysiological responses involving inflammation [1] [2] [3] [4] . In response to a stimulus PAF is rapidly synthesized via remodeling of 1-O-alkyl-2-acyl-sn-glycero-3-phosphocholine precursors, and is rapidly degraded by PAF acetylhydrolases [5] [6] [7] . Several techniques for PAF quantitation have been applied in the past, which have their merits and limitations. PAF was originally quantitated by biological responsiveness by platelets, which, while sensitive and ground-breaking, lacked structural detail regarding molecules responsible for platelet activation [8] . An enzyme-linked immunosorbent assay (ELISA) is commercially available and is sensitive to ~200 fmol, but is expensive, lacks structural detail of PAF molecular species, and is susceptible to preparative loss of PAF by PAF acetylhydrolase. A sensitive gas chromatography-mass spectrometry method for PAF quantification includes phospholipase C conversion of PAF to diglycerides and subsequent conversion of the Abstract Platelet-activating factor (PAF) is a potent biologically active phospholipid that mediates human physiological and pathophysiologic responses. PAF levels increase transiently and are typically assessed by techniques with limitations related to expense, sensitivity, pre-analysis derivatization and interference with isobaric molecules. This study elucidates a facile, accurate liquid chromatography-mass spectrometry analytical method for PAF. In negative ion mode using electrospray ionization, collisionally-activated dissociation analysis showed a unique product ion for acetate adducts of PAF molecular species representing the loss of methyl acetate from the polar head group and loss of a part of the acetate group from the sn-2 position. This product ion was exploited for selected reaction monitoring of PAF molecular species following separation by reversed-phase liquid chromatography. Standard calibration responses were determined, and this method was able to detect as low as 100 fmol of PAF. Finally, PAF molecular species were quantified in human neutrophils and monocytes.
diglyceride to a pentafluorobenzoyl derivative [9] . This method is time consuming with the multiple derivatization steps. Finally, several liquid chromatography-mass spectrometry (LC-MS) methods have been reported. Electrospray ionization (ESI) in the positive ion mode has been used to quantitate PAF species with selected reaction monitoring (SRM) detection using the common choline glycerophospholipid product ion m/z 184 [10] . While this method reportedly detects PAF as low as 2 fmol, this method is highly dependent on adequate resolution of 16:0 PAF from isobaric 18:0 lysophosphatidylcholine isomers, which have the same precursor and product ion as 16:0 PAF. ESI in the negative ion mode has been used to quantitate PAF species following straight phase liquid chromatography with SRM detection using the acetate product ion m/z 59 and precursor ion of the deprotonated m/z-15 ion with detection levels as low as 1 pmol [11] . The present study used reversed-phase liquid chromatography (RPLC) and detection of acetate adducts in negative ion mode employing a PAF-specific product ion with SRM detection at levels as low as 100 fmol. :0 PAF, respectively. Q2 was set at 31 eV at 1.0 atm argon. ESI was in the negative ion mode with spray voltage at 3200 eV, vaporizer temperature at 290 °C, sheath gas at 33 psi, auxiliary gas at 10 psi, and capillary temperature at 270 °C. Initial mass spectrometry studies elucidated the fragmentation of PAF molecular species using direct infusion and collisionally-activated dissociation (CAD).
Materials and Methods

Materials, RPLC and Mass Spectrometry
Human Neutrophil and Monocyte Isolation and Stimulation
Human neutrophils were isolated from peripheral blood in the presence of 5.4 mM EDTA and subjected to Polymorph Prep™ density gradient centrifugation (density 1.113 g/ mL; 500×g for 30 min). Neutrophils were prepared according to Polymorph manufacturer's directions and as previously described [12, 13] . Cells were counted on a hemocytometer and diluted to 1 × 10 6 cells/mL in Hanks' buffered saline solution (HBSS) containing Mg 2+ and Ca
2+
. Human monocytes were isolated from peripheral blood (3.8 units heparin/mL blood) and subjected to Ficoll-Paque density gradient centrifugation (density, 1.077 g/mL; 400×g for 20 min). Cells were diluted to 1 × 10 6 cells/mL in Iscove's modified Dulbecco's medium (IMDM) (10 % FBS, penicillin-streptomycin) and then were subjected to a 46 % Percoll density gradient centrifugation in IMDM media with 10 % fetal bovine serum and penicillin-streptomycin (550×g for 30 min). Monocytes were washed twice with ice-cold HBSS and then diluted to 1 × 10 6 cells/mL. For both monocytes and neutrophils, reactions were assembled with 2 mL of cells in HBSS and treated with vehicle, 2.5 µM A23187, or 10 µg/mL LPS. Incubations were for 30 min at 37 °C and stopped with the addition of methanol. Lipids were subsequently subjected to a modified BlighDyer extraction with 4.74 pmol of [d 4 ] 16:0 PAF added [14] . Lipids in the chloroform extract were dried under nitrogen and suspended in 70 μL of mobile phase A prior to LC-MS analyses of PAF molecular species.
Results and Discussion
One of the major problems with mass spectrometry of PAF is that the predominant PAF molecular species, 16:0 PAF is isobaric with 18:0 LPC and their positive charged ions and the primary ion fragments are associated with the phosphocholine headgroup [15] . Thus, the presence of 18:0 LPC at abundances 2-3fold greater than that of 16:0 PAF in biological matrices confounds the quantification of PAF in positive ion mode. Accordingly, initial ESI-MS analysis was performed in the negative ion mode with 16:0 PAF in mobile phase A (containing ammonium acetate). The predominant negative ion m/z 582.5 (acetate adduct) was observed in negative ion mode, and CAD analysis of m/z 582.5 (Fig. 1a) revealed a predominant fragment ion at m/z 466.4 resulting from the loss of methyl acetate from the head group, and part of the acetate group at the sn-2 position. The other assignments for fragment ions observed in These amounts are comparable to previous studies using negative ion mode mass spectrometry, but with straight phase chromatography and a SRM of the M-15 precursor and the acetate anion product ion fragment [16] . Although this previous study separated the molecular species produced in the presence of A23187, they reported the total PAF (sum of the amounts of the molecular species measured). Further studies used this RPLC method to determine the accumulation of PAF molecular species in monocytes treated with LPS and A23187 (Table 1) . It should be noted that plasmalogen PAF has previously been reported in the plasmenylethanolamine pool [17] , and has been suggested to be present in the plasmenylcholine pool [18] . Thus, if plasmenylcholine analog of PAF with 18:0 at the sn-1 position is produced in neutrophils and monocytes it likely would have a similar fragmentation pattern and SRM as 18:1 PAF. This potential artifact could be assessed using the described analytical approach in samples pretreated with acid to remove plasmalogens. Collectively, these studies provide an accurate technique to measure PAF molecular species in biological specimens at levels as low as 100 fmol.
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